Interventional Cardiology Fellowship at The Mount Sinai Hospital

The Interventional Cardiology Fellowship at Mount Sinai Hospital is designed to train qualified applicants in various aspects of percutaneous coronary, non-coronary and endovascular interventions.  It is a one-year fellowship after a formal three-year cardiology fellowship. Graduates of our training program are expected to be fully proficient in performing all aspects of interventional techniques such as:

  • Balloon angioplasty (PTCA)
  • Percutaneous Coronary Intervention (PCI)
  • Rotational atherectomy
  • Orbital atherectomy
  • Laser atherectomy
  • Rheolytic thrombectomy
  • Distal embolic protection devices 
  • Balloon aortic and mitral valvuloplasty
  • LV Assist devices including IABP, Impella, LVAD
  • Intravascular ultrasound (IVUS)
  • Fractional flow reserve (FFR)
  • Optical computed tomography (OCT).
  • Assist in Transcatheter Aortic Valve Replacement (TAVR) procedures under the structural heart program.
  • Diagnostic and interventional peripheral vascular procedures under the endovascular program.

We have a busy academic schedule with regular educational activities include case presentations, journal club, research publications and board review.  The Mount Sinai Cath lab performs over 5,000 interventions every year.  We see a large volume of referred cases with high risk features, thus providing our trainees with ample exposure to complex PCI cases. Typically, 1 to 3 fellows are selected from our own institution, 4 to 5 fellows from outside institutions within the USA, and two fellows from out of the country with a clear intention to return to their country after completing the interventional training.  Each fellow can expect to perform between 400 and 500 interventions with progressive responsibility as an independent operator.

The top features of our Interventional Cardiology Fellowship Program include:

  1. Opportunity to actively learn side by side with some of the most skillful and  experienced operators in the world, led by Samin Sharma, MD and Annapoorna Kini, MD.
  2. An exceptionally high proportion of complex interventions are performed annually at Mount Sinai, allowing our fellows to gain confidence by hands-on learning as primary operators.
  3. Education with all available cutting-edge technology from faculty that are leaders in the field of Interventional Cardiology.
  4. Mount Sinai Heart, ranked #8 nationally by US News and World Report (2016), led by Valentin Fuster, MD, MACC and Editor-in-Chief of Journal of the American College of Cardiology (JACC).
  5. Exceptional volume of collaboration with the Cardiovascular Surgery, Heart Valve Team and the Mitral Valve Reference center, led by David Adams, MD.
  6. Clinical research—Mount Sinai’s dedicated Interventional Cardiology Research Department, lead by Roxana Mehran, MD, with multiple active clinical trials, is often a high enroller and at the forefront of medical research.
  7. Work closely with Mount Sinai faculty who are editors of major heart journals, including: the Journal of American College of Cardiology (JACC)JACC Cardiovascular Imaging,and CardioSource WorldNews Interventions.
  8. Participation in live clinical cases, including webcasts and the annual CCVVC symposium.
  9. Inspiration to strive for the highest levels of technical excellence, safety and appropriateness.  Mount Sinai ranked #1 in New York State for clinical outcomes and safety.
  10. A remarkable and collegial family of physicians, nurses, technicians and staff with a shared commitment to excellence and a love for what we do.

Current Fellows AY 2017-18

Residency

Fellowship

ACGME

 

 

Samit Bhateja, MD 

Quillen College of Medicine, East Tennessee State University

Quillen College of Medicine, East Tennessee State University

Surbhi Chamaria, MD 

Henry Ford Hospital

LSU Health, Shreveport, LA

Muhammad Fahad Khan, MD

University at Buffalo   

New York Methodist Hospital

Nish Patel, MD

University of Oklahoma Health Sciences Center

University of Miami Miller School of Medicine Jackson Memorial Hospital

Neeraj Nailesh Shah, MD

Staten Island University Hospital, NY

Lejigh Valley Health Network, Allentown, PA

Sagar Mallikethi Lepakshi Reddy, MD 

Wayne State University, Detroit Medical Center

Wayne State University, Detroit Medical Ctr.

Sunil Agarwal, MD

University of Pittsburgh Medical Center, Johns Hopkins Hospital

The Mount Sinai Hospital, NYC (Academic Track)

Asma Khaliq, MD

University of Florida

University of Florida

Jossef Amirian, MD

North Shore LIJ 

Mount Sinai Beth Israel

Non-ACGME

 

 

Matias Yudi, MD 

Queensland Health, Australia

-Royal Melbourne Hospital

-St. Vincent's Hospital, Melbourne

-Austin Health, Melbourne, Australia

Farhan Majeed, MD

University of Nebraska Medical Center          

-University of Maryland Medical Center, Baltimore

-The Mount Sinai Hospital, NYC

Sandeep Singla, MD

University of Arkansas for Medical Sciences, Little Rock, Arkansas

-University of Arkansas for Medical Sciences, Little Rock

-Mount Sinai Medical Center, Miami Beach, FL

 

Annapoorna S. Kini, MD, Director of Interventional Cardiology Fellowship,  Director of Cardiac Cath Lab, Professor of Medicine (Cardiology), Zena and Michael A. Wiener Professor of Medicine

Samin K. Sharma, MD, Director of Clinical and Interventional Cardiology and Professor of Medicine (Cardiology), Anandi Lal Sharma Professor of Medicine in Cardiology

George Dangas, MD, PhD, Director of Cardiovascular Innovation and Professor Medicine  (Cardiology).

Joseph M. Sweeny, MD, Associate Director of Interventional Cardiology Fellowship and Assistant Professor of Medicine (Cardiology). 

Nitin Barman, MD, Assistant Professor of Medicine  (Cardiology) 

The primary objective of the Interventional Cardiology Fellowship at Mount Sinai hospital is to provide extensive training in the endovascular management of patients with cardiovascular disease. The program provides excellent hands on training opportunities in various aspects of coronary, structural and endovascular interventions. The graduates of our program often take on leadership roles in the field of interventional cardiology.

Goals & Objectives:

  • Training on interventional equipment such as guiding catheters, balloons, stents and devices. 
  • Didactic discussions on appropriate interventional techniques for specific lesions. 
  • Insertion and management of IABP, Impella and percutaneous LVAD.
  • Use of Rotational and Orbital Atherectomy, rheolytic atherectomy (Angiojet) and manual aspiration thrombectomy.
  • Selection and deployment of appropriate distal embolic protection devices.  
  • Setup, perform and interpret FFR, IVUS and OCT during this time period.
  • Selection of patients and performing balloon aortic and mitral valvuloplasty.
  • Perform intervention in chronic total occlusions (CTO) by anterograde and retrograde approaches.
  • Knowledge of peripheral vascular disease, patient selection, and diagnostic and invasive endovascular procedures including iliac/CFA/SFA interventions.
  • Encouraged to take an active role in Transcatheter Aortic Valve Replacement (TAVR) procedures as well.
  • Fellows are also expected to have full understanding of endovascular interventions and are expected to have actively participated in over 80 endovascular procedures. 

At the end of the year an interventional fellow will be proficient in all aspects of cardiac catheterization and all different types of coronary interventions, balloon aortic valvuloplasty and non-complex endovascular interventions in a safe and confident manner.

ACGME requirement of 250 coronary interventions will be easily met, and our fellows average 400-500 coronary cases as primary operator in addition to additional cases in valvular (20-25) and peripheral interventions(90-110).

We offer additional 1-year training programs in both Structural Heart and Endovascular Interventions.

Rotations:

  1. Core laboratory rotations: On a weekly basis, interventional fellows will rotate through the laboratory’s seven rooms, gaining experience with different faculty members and a comprehensive array of coronary, peripheral and structural interventions.
  2. On Call: Approximately once every eight weeks, interventional fellows will be assigned to be On Call for the calendar week. During the On Call week, which includes night and weekend coverage of the interventional service, fellows will have primary responsibility for emergent consultations and procedures.
  3. Research: Approximately once every eight weeks, interventional fellows will be assigned to a one week research rotation. 
  4. Clinic: One half-day per week, each interventional fellow will attend the interventional cardiology clinic with an attending physician.

Interventional fellows are expected to perform clinical research related to intervention cardiology and to contribute scholarly writing in the field.  Each fellow will be assigned to one or two clinical research projects with an expectation of completion during the fellowship year.  Original clinical research would require formulation of ideas, writing of protocol, collection of patients', analysis of data and submission as abstract and manuscript. Multimodality intravascular imaging is one area of the potential research areas. Cath lab has an extensive retrospective imaging database including hundreds of IVUS, NIRS and OCT cases. The YELLOW series of prospective clinical trials offers a rare combination of coronary imaging and basic science research including gene expression analysis. Advanced imaging techniques, such as 3D QCA and 3D OCT reconstruction, are used in our ORBID trials in order to find predictors of side branch occlusion after main vessel stenting.   To learn more about the research available to our fellows, please click here

We will be accepting applications for positions starting July 1, 2019.

For ACGME applications:  please use ERAS.

Note:  Please send these additional documents to the program coordinator via email:

  • Copies of any published abstracts and manuscripts
  • Procedure Log detailing procedural training done and signed by the Cath Lab Director 

For Non-ACGME applications (non U.S. applicants with the intention of returning to their home country), and Advanced Fellowship in Structural Heart Disease:

Please email to Maria Directo at maria.directo@mountsinai.org the following: 

  • Interventional Cardiology Application Form
  • Current CV
  • Personal statement
  • 3 Recommendation Letters (1 recommendation from the Cath Lab Director)
  • Copy of ECFMG certification
  • Copies of any published abstracts and manuscripts
  • Procedure Log detailing procedural training done and signed by the Cath Lab Director.